Cargando…
Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
Interstitial lung diseases (ILDs) comprise a wide group of pulmonary parenchymal disorders. These patients may experience acute respiratory deteriorations of their respiratory condition, termed “acute exacerbation” (AE). The incidence of AE-ILD seems to be lower than idiopathic pulmonary fibrosis (I...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465527/ https://www.ncbi.nlm.nih.gov/pubmed/34573965 http://dx.doi.org/10.3390/diagnostics11091623 |
_version_ | 1784572898004959232 |
---|---|
author | Faverio, Paola Stainer, Anna Conti, Sara Madotto, Fabiana De Giacomi, Federica Della Zoppa, Matteo Vancheri, Ada Pellegrino, Maria Rosaria Tonelli, Roberto Cerri, Stefania Clini, Enrico M. Mantovani, Lorenzo Giovanni Pesci, Alberto Luppi, Fabrizio |
author_facet | Faverio, Paola Stainer, Anna Conti, Sara Madotto, Fabiana De Giacomi, Federica Della Zoppa, Matteo Vancheri, Ada Pellegrino, Maria Rosaria Tonelli, Roberto Cerri, Stefania Clini, Enrico M. Mantovani, Lorenzo Giovanni Pesci, Alberto Luppi, Fabrizio |
author_sort | Faverio, Paola |
collection | PubMed |
description | Interstitial lung diseases (ILDs) comprise a wide group of pulmonary parenchymal disorders. These patients may experience acute respiratory deteriorations of their respiratory condition, termed “acute exacerbation” (AE). The incidence of AE-ILD seems to be lower than idiopathic pulmonary fibrosis (IPF), but prognosis and prognostic factors are largely unrecognized. We retrospectively analyzed a cohort of 158 consecutive adult patients hospitalized for AE-ILD in two Italian university hospitals from 2009 to 2016. Patients included in the analysis were divided into two groups: non-IPF (62%) and IPF (38%). Among ILDs included in the non-IPF group, the most frequent diagnoses were non-specific interstitial pneumonia (NSIP) (42%) and connective tissue disease (CTD)-ILD (20%). Mortality during hospitalization was significantly different between the two groups: 19% in the non-IPF group and 43% in the IPF group. AEs of ILDs are difficult-to-predict events and are burdened by relevant mortality. Increased inflammatory markers, such as neutrophilia on the differential blood cell count (HR 1.02 (CI 1.01–1.04)), the presence of pulmonary hypertension (HR 1.85 (CI 1.17–2.92)), and the diagnosis of IPF (HR 2.31 (CI 1.55–3.46)), resulted in negative prognostic factors in our analysis. Otherwise, lymphocytosis on the differential count seemed to act as a protective prognostic factor (OR 0.938 (CI 0.884–0.995)). Further prospective, large-scale, real-world data are needed to support and confirm the impact of our findings. |
format | Online Article Text |
id | pubmed-8465527 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84655272021-09-27 Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases Faverio, Paola Stainer, Anna Conti, Sara Madotto, Fabiana De Giacomi, Federica Della Zoppa, Matteo Vancheri, Ada Pellegrino, Maria Rosaria Tonelli, Roberto Cerri, Stefania Clini, Enrico M. Mantovani, Lorenzo Giovanni Pesci, Alberto Luppi, Fabrizio Diagnostics (Basel) Article Interstitial lung diseases (ILDs) comprise a wide group of pulmonary parenchymal disorders. These patients may experience acute respiratory deteriorations of their respiratory condition, termed “acute exacerbation” (AE). The incidence of AE-ILD seems to be lower than idiopathic pulmonary fibrosis (IPF), but prognosis and prognostic factors are largely unrecognized. We retrospectively analyzed a cohort of 158 consecutive adult patients hospitalized for AE-ILD in two Italian university hospitals from 2009 to 2016. Patients included in the analysis were divided into two groups: non-IPF (62%) and IPF (38%). Among ILDs included in the non-IPF group, the most frequent diagnoses were non-specific interstitial pneumonia (NSIP) (42%) and connective tissue disease (CTD)-ILD (20%). Mortality during hospitalization was significantly different between the two groups: 19% in the non-IPF group and 43% in the IPF group. AEs of ILDs are difficult-to-predict events and are burdened by relevant mortality. Increased inflammatory markers, such as neutrophilia on the differential blood cell count (HR 1.02 (CI 1.01–1.04)), the presence of pulmonary hypertension (HR 1.85 (CI 1.17–2.92)), and the diagnosis of IPF (HR 2.31 (CI 1.55–3.46)), resulted in negative prognostic factors in our analysis. Otherwise, lymphocytosis on the differential count seemed to act as a protective prognostic factor (OR 0.938 (CI 0.884–0.995)). Further prospective, large-scale, real-world data are needed to support and confirm the impact of our findings. MDPI 2021-09-06 /pmc/articles/PMC8465527/ /pubmed/34573965 http://dx.doi.org/10.3390/diagnostics11091623 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Faverio, Paola Stainer, Anna Conti, Sara Madotto, Fabiana De Giacomi, Federica Della Zoppa, Matteo Vancheri, Ada Pellegrino, Maria Rosaria Tonelli, Roberto Cerri, Stefania Clini, Enrico M. Mantovani, Lorenzo Giovanni Pesci, Alberto Luppi, Fabrizio Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases |
title | Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases |
title_full | Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases |
title_fullStr | Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases |
title_full_unstemmed | Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases |
title_short | Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases |
title_sort | differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465527/ https://www.ncbi.nlm.nih.gov/pubmed/34573965 http://dx.doi.org/10.3390/diagnostics11091623 |
work_keys_str_mv | AT faveriopaola differencesbetweenacuteexacerbationsofidiopathicpulmonaryfibrosisandotherinterstitiallungdiseases AT staineranna differencesbetweenacuteexacerbationsofidiopathicpulmonaryfibrosisandotherinterstitiallungdiseases AT contisara differencesbetweenacuteexacerbationsofidiopathicpulmonaryfibrosisandotherinterstitiallungdiseases AT madottofabiana differencesbetweenacuteexacerbationsofidiopathicpulmonaryfibrosisandotherinterstitiallungdiseases AT degiacomifederica differencesbetweenacuteexacerbationsofidiopathicpulmonaryfibrosisandotherinterstitiallungdiseases AT dellazoppamatteo differencesbetweenacuteexacerbationsofidiopathicpulmonaryfibrosisandotherinterstitiallungdiseases AT vancheriada differencesbetweenacuteexacerbationsofidiopathicpulmonaryfibrosisandotherinterstitiallungdiseases AT pellegrinomariarosaria differencesbetweenacuteexacerbationsofidiopathicpulmonaryfibrosisandotherinterstitiallungdiseases AT tonelliroberto differencesbetweenacuteexacerbationsofidiopathicpulmonaryfibrosisandotherinterstitiallungdiseases AT cerristefania differencesbetweenacuteexacerbationsofidiopathicpulmonaryfibrosisandotherinterstitiallungdiseases AT clinienricom differencesbetweenacuteexacerbationsofidiopathicpulmonaryfibrosisandotherinterstitiallungdiseases AT mantovanilorenzogiovanni differencesbetweenacuteexacerbationsofidiopathicpulmonaryfibrosisandotherinterstitiallungdiseases AT pescialberto differencesbetweenacuteexacerbationsofidiopathicpulmonaryfibrosisandotherinterstitiallungdiseases AT luppifabrizio differencesbetweenacuteexacerbationsofidiopathicpulmonaryfibrosisandotherinterstitiallungdiseases |